Cargando…
External validation of the QLifetime cardiovascular risk prediction tool: population cohort study
BACKGROUND: Prediction of lifetime cardiovascular disease (CVD) risk is recommended in many clinical guidelines, but lifetime risk models are rarely externally validated. The aim of this study was to externally validate the QRiskLifetime incident CVD risk prediction tool. METHODS: Independent extern...
Autores principales: | Livingstone, Shona, Morales, Daniel R., Fleuriot, Jacques, Donnan, Peter T., Guthrie, Bruce |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10105395/ https://www.ncbi.nlm.nih.gov/pubmed/37061672 http://dx.doi.org/10.1186/s12872-023-03209-8 |
Ejemplares similares
-
Effect of competing mortality risks on predictive performance of the QRISK3 cardiovascular risk prediction tool in older people and those with comorbidity: external validation population cohort study
por: Livingstone, Shona, et al.
Publicado: (2021) -
Effect of competing mortality risks on predictive performance of the QFracture risk prediction tool for major osteoporotic fracture and hip fracture: external validation cohort study in a UK primary care population
por: Livingstone, Shona J, et al.
Publicado: (2022) -
Predictive performance of a competing risk cardiovascular prediction tool CRISK compared to QRISK3 in older people and those with comorbidity: population cohort study
por: Livingstone, Shona J., et al.
Publicado: (2022) -
Respiratory effect of beta-blockers in people with asthma and cardiovascular disease: population-based nested case control study
por: Morales, Daniel R., et al.
Publicado: (2017) -
Patient outcomes following AKI and AKD: a population-based cohort study
por: Wang, Huan, et al.
Publicado: (2022)